-
Leerink Partners Initiates Tekmira Pharmaceuticals At Outperform
Monday, August 18, 2014 - 8:00am | 40Read More...Analysts at Leerink Partners initiated coverage on Tekmira Pharmaceuticals (NASDAQ: TKMR) with a Outperform rating. The target price for Tekmira Pharmaceuticals is set to $25. Tekmira Pharmaceuticals' shares gained 6.08% to $19.18 in pre-market trading.
